Related Experiment Video
Updated: Dec 22, 2025
04:56
Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
973
Antibiotic therapy for Helicobacter pylori
Jason Collins1, Amira Ali-Ibrahim, Duane T Smoot
1Gastroenterology Section, Department of Medicine, Howard University College of Medicine, Washington, DC 20059, USA.
The Medical Clinics of North America
|November 23, 2006
Summary
Helicobacter pylori (H pylori) infection causes peptic ulcers and gastric cancer. Treatment involves antibiotics and acid reducers, but antibiotic resistance necessitates retreatment with different drugs if initial therapy fails.
Area of Science:
- Gastroenterology
- Microbiology
- Infectious Diseases
Background:
- Helicobacter pylori is a prevalent global bacterial pathogen.
- H pylori infection is the primary cause of peptic ulcers and contributes significantly to gastric cancer development.
- The bacterium's location within gastric mucus poses treatment challenges.
Purpose of the Study:
- To review the challenges and strategies for treating H pylori infections.
- To highlight the importance of appropriate antimicrobial therapy and managing antibiotic resistance.
Main Methods:
- Literature review of H pylori treatment protocols.
- Analysis of antimicrobial resistance patterns in H pylori.
- Evaluation of combination therapies including antibiotics and acid suppressants.
Main Results:
- Standard H pylori treatment combines multiple antibiotics with proton pump inhibitors or histamine receptor antagonists.
- Antibiotic resistance is a significant complication, often requiring treatment modification.
- Successful retreatment relies on employing alternative antibiotic regimens.
Conclusions:
- Effective H pylori eradication requires careful selection of antibiotics to overcome resistance.
- Management strategies must adapt to evolving antimicrobial resistance patterns.
- Further research into novel therapeutic approaches is warranted.
